Sharekhan

Vineet Laboratories Ltd

Fri 2/01/2026,15:43:20 NSE: VINEETLAB

₹ 34.41 -1.46 (-4.07%)
BUY NOW Buy Vineet Laboratories Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Vineet Laboratories Ltd

Fri 2/01/2026,16:1:0

Vineet Laboratories Ltd

Fri 2/01/2026,15:43:20 | NSE : VINEETLAB

₹ 34.41-1.46 (-4.07%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 35.20

Previous Close

₹ 35.87

Volume

62693

Mkt Cap ( Rs. Cr)

₹66.09

High

₹ 36.00

Low

₹ 33.80

52 Week High

₹ 45.05

52 Week Low

₹ 28.32

Book Value Per Share

₹ 23.00

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Vineet Laboratories Ltd

Your Vote -

Buy

33.33%

Hold

0.00%

Sell

66.67%

33.33%

3 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

34.41

1

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

1

Option Chain

Analyzes market sentiment, predicts Vineet Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Vineet Laboratories - Copy of Newspaper Publication

    29 Dec 2025, 1:46PM We are hereby submitting the Newspaper Advertisements published before the date of opening of the Rights Issue as required under Regulation 84(1) of S

  • Vineet Laboratories - Trading Window

    27 Dec 2025, 2:10PM Vineet Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulatio

  • Vineet Laboratories - General Updates

    20 Dec 2025, 2:30PM The Company is hereby submitting the Letter of Offer for Rights Issue.

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Raising of Funds

    20 Dec 2025, 2:22PM The Company is hereby submitting the Letter of Offer for Rights Issue.

  • Vineet Laboratories - Updates

    17 Dec 2025, 5:21PM The Company has made necessary arrangements with NSDL and CDSL for credit of Rights Entitlements in dematerialized form in the demat accounts of the E

  • Vineet Laboratories - Record Date

    17 Dec 2025, 3:25PM Vineet Laboratories Limited has informed the Exchange that Record date for the purpose of Rights Issue is Tuesday, December 23, 2025.

  • Vineet Laboratories - Committee Meeting Updates

    17 Dec 2025, 3:22PM We hereby inform that the Rights Issue Committee of the Board in its meeting held today i.e. on December 17, 2025 has inter alia considered and approv

  • Vineet Laboratories - General Updates

    17 Dec 2025, 11:03AM The Company has received the In-Principle approval(s) from National Stock Exchange of India Limited on December 02, 2025 and BSE Limited on December 1

  • Vineet Laboratories - Intimation Of International Securities Identification Number ('ISIN') For The Rights Entitlements To Be

    17 Dec 2025, 5:05PM The Company has made necessary arrangements with NSDL and CDSL for credit of Rights Entitlements in dematerialized form in the demat accounts of the E

  • Vineet Laboratories - Corporate Action-Intimation of Right issue

    17 Dec 2025, 3:38PM We hereby inform that the Rights Issue Committee of the Board in its meeting held today, i.e., December 17, 2025 has inter alia considered and approve

  • Vineet Laboratories - The Record Date For The Proposed Rights Issue Is Tuesday, December 23, 2025.

    17 Dec 2025, 3:27PM We hereby inform that the Rights Issue Committee in its meeting held today, December 17, 2025 has approved the Record Date for the proposed Rights Iss

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Raising of Funds

    17 Dec 2025, 3:19PM We hereby inform that the Rights Issue Committee of the Board in its meeting held today i.e. on December 17, 2025 has inter alia considered and approv

  • Vineet Laboratories - Intimation Of Receipt Of In-Principle Approval From BSE And NSE For Rights Issue

    17 Dec 2025, 10:57AM The Company has received the In-Principle approval(s) from National Stock Exchange of India Limited on December 02, 2025 and BSE Limited on December 1

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Meeting Updates

    16 Dec 2025, 7:00PM In continuation to our communication dated December 15, 2025, regarding convening of meeting of Rights Issue Committee on December 16, 2025, we inform

  • Vineet Laboratories - Committee Meeting Updates

    16 Dec 2025, 6:58PM In continuation to our communication dated December 15, 2025, regarding the convening of the meeting of Rights Issue Committee on December 16, 2025, w

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Meeting Updates

    15 Dec 2025, 9:25PM In continuation to our communication dated December 12, 2025, regarding the convening of meeting of Rights Issue Committee on December 15, 2025, we in

  • Vineet Laboratories - Committee Meeting Updates

    12 Dec 2025, 6:16PM In continuation to our communication dated December 11, 2025, regarding the convening of the meeting of Rights Issue Committee on December 12, 2025, w

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Meeting Updates

    12 Dec 2025, 6:15PM In continuation to our communication dated December 11, 2025, regarding the convening of the meeting of the Rights Issue Committee on December 12, 202

  • Vineet Laboratories - Committee Meeting Updates

    11 Dec 2025, 6:38PM In continuation to our communication dated December 09, 2025, regarding the convening of the meeting of Rights Issue Committee on December 11, 2025, w

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Meeting Updates

    11 Dec 2025, 6:36PM In continuation to our communication dated December 09, 2025, regarding convening of the meeting of the Rights Issue Committee on December 11, 2025, w

  • Vineet Laboratories - Committee Meeting Updates

    9 Dec 2025, 6:36PM In continuation to our communication dated December 06, 2025, regarding convening of the meeting of Rights Issue Committee on December 09, 2025, we in

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Meeting Updates

    9 Dec 2025, 6:33PM In continuation to our communication dated December 06, 2025, regarding convening of the meeting of Rights Issue Committee on December 09, 2025, we in

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Meeting Updates

    6 Dec 2025, 6:33PM In continuation of our communication dated December 03, 2025, regarding the convening of the meeting of the Rights Issue Committee on December 06, 202

  • Vineet Laboratories - Committee Meeting Updates

    6 Dec 2025, 6:30PM In continuation to our communication dated December 03, 2025, regarding the convening of the meeting of Rights Issue Committee on December 06, 2025, w

  • Vineet Laboratories - Committee Meeting Updates

    3 Dec 2025, 6:03PM In continuation to our intimation dated November 27, 2025, regarding the convening of the meeting of Rights Issue Committee on December 03, 2025, we i

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Meeting Updates

    3 Dec 2025, 5:56PM In continuation of our intimation dated November 27, 2025 regarding the convening of the meeting of Rights Issue Committee on December 03, 2025, we in

  • Vineet Laboratories - Prior Intimation Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulati

    27 Nov 2025, 6:36PM We would like to inform you that a meeting of the Rights Issue Committee of the Board is scheduled to be held on Wednesday, December 03, 2025 to consi

  • Vineet Laboratories - Committee Meeting Updates

    27 Nov 2025, 6:36PM This communication is in furtherance to the outcome of Board Meeting held on November 27,2025 approving the Rights Issue of fully paid-up Equity share

  • Vineet Laboratories - General Updates

    27 Nov 2025, 4:28PM Vineet Laboratories Limited has informed that the Draft Letter of Offer for the proposed Rights issue has been submitted to BSE Limited, National Stoc

  • Vineet Laboratories - Rights Issue

    27 Nov 2025, 12:57PM The Board of Directors of Vineet Laboratories Limited at its meeting held today i.e., on Thursday, November 27, 2025, approved the following:1. Raise

  • Vineet Laboratories - Issue of Securities

    27 Nov 2025, 12:54PM The Board of Directors of Vineet Laboratories Limited at its meeting held today i.e., on Thursday, November 27, 2025, approved the following:1. Raise

  • Vineet Laboratories - Outcome of Board Meeting

    27 Nov 2025, 12:46PM Vineet Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held today i.e., on Thursday, November

  • Vineet Laboratories - Intimation Of Submission Of Draft Letter Of Offer For The Proposed Rights Issue

    27 Nov 2025, 4:39PM We hereby inform that the Draft Letter of Offer for the proposed Rights Issue has been submitted to BSE Limited, National Stock Exchange of India Limi

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Raising of Funds

    27 Nov 2025, 1:03PM We hereby Inform that the Board of Directors in its meeting held today i.e., on Thursday, November 27, 2025, approved to raise funds by way of issue o

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Issue of Securities

    27 Nov 2025, 12:55PM We hereby inform that the Board of Directors of the Company at its meeting held today i.e., on Thursday, November 27, 2025, approved to raise funds by

  • Vineet Laboratories - Board Meeting Intimation for Fund Raising By Way Of Issue Of Equity Shares Through Rights Issue.

    24 Nov 2025, 5:56PM Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/11/2025 ,inter alia, to consider

  • Vineet Laboratories - Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015

    18 Nov 2025, 6:07PM We are hereby submitting the intimation received from Satyanarayan Raju Bhupathiraju, Alluri Srinivas Raju, Alluri Ranga Raju, Alluri Prabhakar Raju,

  • Vineet Laboratories - Updates

    18 Nov 2025, 5:34PM Vineet Laboratories Limited has informed the Exchange regarding 'Intimation received from Satyanarayana Raju Bhupathiraju, Alluri Srinivasa Raju, Allu

  • Vineet Laboratories - Copy of Newspaper Publication

    14 Nov 2025, 6:16PM We are hereby submitting the newspaper advertisements in Financial Express (English Language) and Nava Telangana (Telugu Language) regarding the Unaud

  • Vineet Laboratories - Appointment

    8 Nov 2025, 5:07PM Vineet Laboratories Limited has informed the Exchange regarding Appointment of Ms Jasmin Kunal Tailor as Non- Executive Independent Director of the co

  • Vineet Laboratories posts Q2 net profit of Rs 0.40 cr

    8 Nov 2025, 5:01PM The company reported standalone net profit during the quarter stood at Rs 0.40 crore compared to net loss of Rs 1.83 crore in the previous year quarte

  • Vineet Laboratories - Resignation

    8 Nov 2025, 5:00PM Vineet Laboratories Limited has informed the Exchange regarding Resignation of Ms Hari Priya Yerukalapudi as Non- Executive Independent Director of th

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Change in Management

    8 Nov 2025, 4:57PM The Board of Directors in its meeting held today i.e. on Saturday, November 08, 2025, has approved the appointment of Ms. Jasmin Kunal Tailor (DIN: 10

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Resignation of Director

    8 Nov 2025, 4:51PM The Board of Directors in its meeting held today i.e. on Saturday, November 08, 2025 has noted the resignation of Ms. Hari Priya Yerukalapudi (DIN: 09

  • Vineet Laboratories - Resignation of Independent director

    8 Nov 2025, 4:45PM VINEET LABORATORIES LIMITED has informed the Exchange about Resignation of Independent director.

  • Vineet Laboratories - Unaudited Standalone Financial Results Of The Company For The Second Quarter And The Half Year Ended On

    8 Nov 2025, 4:41PM The Board of Directors in their meeting held today i.e. on November 08, 2025 has approved the Unaudited Standalone Financial Results for the Second Qu

  • Vineet Laboratories - Outcome of Board Meeting

    8 Nov 2025, 4:40PM Vineet Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.

  • Vineet Laboratories - Outcome of Board Meeting

    8 Nov 2025, 4:27PM The Board of Directors of the company in its meeting held today i.e., Saturday, November 08, 2025 has: considered and approved the unaudited standalo

  • Vineet Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, November 08, 2025 As Required Unde

    8 Nov 2025, 4:26PM The Board of Directors of the company in its meeting held today i.e., Saturday, November 08, 2025 has: \r\n\r\n approved the unaudited standalone fin

  • Vineet Laboratories - Board Meeting Intimation for Considering The Unaudited Standalone Financial Results Of The Company For

    4 Nov 2025, 7:24PM Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 ,inter alia, to consider

  • Vineet Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    18 Oct 2025, 6:50PM As of September 2025, 15.89% is owned by Indian Promoters and 84.11% by Public. <p align=justify> Top five Promoters holding highest number of shares

  • Vineet Laboratories - Cancellation of Board Meeting

    18 Oct 2025, 5:17PM The Board Meeting to be held on 23/10/2025 Stands Cancelled.

  • Vineet Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    14 Oct 2025, 7:17PM We are hereby submitting the certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with Regulation 74(5) of th

  • Vineet Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Oct 2025, 7:10PM We are hereby submitting the certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with Regulation 74(5) of th

  • Vineet Laboratories - Board Meeting Intimation for Considering The Unaudited Standalone Financial Results Of The Company For

    13 Oct 2025, 6:59PM Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2025 ,inter alia, to consider

  • Vineet Laboratories - Updates

    4 Oct 2025, 12:16PM Vineet Laboratories Limited has informed the Exchange regarding 'Intimation received from Mr. Satyanarayana Raju Bhupathiraju, Mr. Alluri Srinivasa Ra

  • Vineet Laboratories - Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015

    4 Oct 2025, 12:05PM We are hereby submitting the intimation received from Mr. Satyanarayana Raju Bhupathiraju, Mr. Alluri Srinivasa Raju, Mr. Ranga Raju Alluri, Mr. Allur
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Vineet Laboratories Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 54.6947 79.0239 64.7723 59.7318 39.0878
Liabilities 54.6947 79.0239 64.7723 59.7318 39.0878
Equity 9.219 9.219 9.219 9.219 9.219
Gross Profit -16.2831 7.2002 7.6597 13.2445 8.1456
Net Profit -20.191 1.0271 1.2525 6.6386 1.7802
Cash From Operating Activities 11.4909 -11.4272 -9.6162 0 -8.7123
NPM(%) -26.92 0.68 0.58 3.47 0.73
Revenue 74.995 150.5913 212.2933 191.1723 243.4789
Expenses 91.2781 143.3911 204.6336 177.9278 235.3333
ROE(%) -45.69 2.32 2.83 15.02 4.02

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
19 Sep 2022 1 10 0 58.75

Peers

Other companies within the same industry or sector that are comparable to Vineet Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 752.70 1.78 0.00 20.41 301.39 0.66
Lotus Eye Hospital and Institute Ltd 121.70 1.04 380.31 74.39 3.55 0.00
Vaishali Pharma Ltd 8.74 2.34 0.00 466.66 3.13 0.00
Astec Lifesciences Ltd 715.15 0.85 0.00 70.15 -604.77 0.00

Company Info

Vineet Laboratories Limited ("Resulting Company") is a public limited company incorporated under the provisions of the Companies Act, 2013, on 10th day of November, 2016. The Corporate Identity Number of Resulting Company is U24304TG2016PLC112888. The objects of the Resulting Company enable it to carry on the business of manufacturing of bulk drugs intermediates and API Intermediates. The PAN of the Company is AAFCV6694P.

Vineet Laboratories Limited ("Resulting Company") is a public limited company incorporated under the provisions of the Companies Act, 2013, on 10th day of November, 2016. The Corporate Identity Number of Resulting Company is U24304TG2016PLC112888. The objects of the Resulting Company enable it to carry on the business of manufacturing of bulk drugs intermediates and API Intermediates. The PAN of the Company is AAFCV6694P.

Read More

Parent Organisation

Vineet Laboratories Ltd.

Founded

10/11/2016

Managing Director

Mr.Gaddam Venkata Ramana

NSE Symbol

VINEETLABEQ

FAQ

The current price of Vineet Laboratories Ltd is ₹ 34.41.

The 52-week high for Vineet Laboratories Ltd is ₹ 36.00 and the 52-week low is ₹ 33.80.

The market capitalization of Vineet Laboratories Ltd is currently ₹ 66.09. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Vineet Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Vineet Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vineet Laboratories Ltd shares.

The CEO of Vineet Laboratories Ltd is Mr.Gaddam Venkata Ramana, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT